Anemia in Chronic Kidney Disease: The State of the Art
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/17284 |
Resumo: | The aging of the population has led to an increased prevalence of chronic diseases such as chronic kidney disease. Anemia is one of the most frequent complications of chronic kidney disease, with an impact not only on the quality of life but also on the patient’s prognosis and associated costs. Knowledge in this therapeutic area has increased significantly: from the appearance of recombinant erythropoietin in 1989, through the use of increasing doses of parenteral iron and, more recently, to new molecules such as hypoxia-inducible factor inhibitors. The aim of this article is to present a pragmatic review of the state of the art in the epidemiology, pathophysiology, diagnosis and treatment of anemia associated with chronic kidney disease. |
id |
RCAP_b425a150bacb458659f3c1a27a6ce07b |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/17284 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Anemia in Chronic Kidney Disease: The State of the ArtAnemia da Doença Renal Crónica: O Estado da ArteAnemia/diagnosisAnemia/drug therapyAnemiaIron-DeficiencyProlyl-Hydroxylase Inhibitors/therapeutic useRenal InsufficiencyChronic/complicationsAnemia/diagnósticoAnemia/tratamento farmacológicoAnemia FerropénicaDoença Renal Crónica/complicaçõesInibidores de Prolil-Hidrolase/uso terapêuticoThe aging of the population has led to an increased prevalence of chronic diseases such as chronic kidney disease. Anemia is one of the most frequent complications of chronic kidney disease, with an impact not only on the quality of life but also on the patient’s prognosis and associated costs. Knowledge in this therapeutic area has increased significantly: from the appearance of recombinant erythropoietin in 1989, through the use of increasing doses of parenteral iron and, more recently, to new molecules such as hypoxia-inducible factor inhibitors. The aim of this article is to present a pragmatic review of the state of the art in the epidemiology, pathophysiology, diagnosis and treatment of anemia associated with chronic kidney disease.O envelhecimento populacional tem-se traduzido no aumento de prevalência de doenças crónicas como a doença renal crónica. A anemia é uma das complicações mais frequentes da doença renal crónica, com impacto não só na qualidade de vida como no prognóstico do doente e nos custos associados. O conhecimento nesta área terapêutica tem aumentado de forma significativa: desde o aparecimento da eritropoietina recombinante em 1989, passando pelo uso de doses crescentes de ferro parentérico e, mais recentemente, a novas moléculas como os inibidores do hypoxia-inducible factor. Os autores pretendem rever, de uma forma pragmática, o estado da arte da anemia associada à doença renal crónica, desde a epidemiologia, à fisiopatologia, ao diagnóstico e ao tratamento.Ordem dos Médicos2022-07-15info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/17284oai:ojs.www.actamedicaportuguesa.com:article/17284Acta Médica Portuguesa; Vol. 35 No. 10 (2022): October; 758-764Acta Médica Portuguesa; Vol. 35 N.º 10 (2022): Outubro; 758-7641646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/17284https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/17284/6697Direitos de Autor (c) 2022 Acta Médica Portuguesahttp://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessFarinha, AnaRobalo Nunes, AntónioMairos, JoãoFonseca, Cândida2022-12-20T11:08:00Zoai:ojs.www.actamedicaportuguesa.com:article/17284Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:20:55.182791Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Anemia in Chronic Kidney Disease: The State of the Art Anemia da Doença Renal Crónica: O Estado da Arte |
title |
Anemia in Chronic Kidney Disease: The State of the Art |
spellingShingle |
Anemia in Chronic Kidney Disease: The State of the Art Farinha, Ana Anemia/diagnosis Anemia/drug therapy Anemia Iron-Deficiency Prolyl-Hydroxylase Inhibitors/therapeutic use Renal Insufficiency Chronic/complications Anemia/diagnóstico Anemia/tratamento farmacológico Anemia Ferropénica Doença Renal Crónica/complicações Inibidores de Prolil-Hidrolase/uso terapêutico |
title_short |
Anemia in Chronic Kidney Disease: The State of the Art |
title_full |
Anemia in Chronic Kidney Disease: The State of the Art |
title_fullStr |
Anemia in Chronic Kidney Disease: The State of the Art |
title_full_unstemmed |
Anemia in Chronic Kidney Disease: The State of the Art |
title_sort |
Anemia in Chronic Kidney Disease: The State of the Art |
author |
Farinha, Ana |
author_facet |
Farinha, Ana Robalo Nunes, António Mairos, João Fonseca, Cândida |
author_role |
author |
author2 |
Robalo Nunes, António Mairos, João Fonseca, Cândida |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Farinha, Ana Robalo Nunes, António Mairos, João Fonseca, Cândida |
dc.subject.por.fl_str_mv |
Anemia/diagnosis Anemia/drug therapy Anemia Iron-Deficiency Prolyl-Hydroxylase Inhibitors/therapeutic use Renal Insufficiency Chronic/complications Anemia/diagnóstico Anemia/tratamento farmacológico Anemia Ferropénica Doença Renal Crónica/complicações Inibidores de Prolil-Hidrolase/uso terapêutico |
topic |
Anemia/diagnosis Anemia/drug therapy Anemia Iron-Deficiency Prolyl-Hydroxylase Inhibitors/therapeutic use Renal Insufficiency Chronic/complications Anemia/diagnóstico Anemia/tratamento farmacológico Anemia Ferropénica Doença Renal Crónica/complicações Inibidores de Prolil-Hidrolase/uso terapêutico |
description |
The aging of the population has led to an increased prevalence of chronic diseases such as chronic kidney disease. Anemia is one of the most frequent complications of chronic kidney disease, with an impact not only on the quality of life but also on the patient’s prognosis and associated costs. Knowledge in this therapeutic area has increased significantly: from the appearance of recombinant erythropoietin in 1989, through the use of increasing doses of parenteral iron and, more recently, to new molecules such as hypoxia-inducible factor inhibitors. The aim of this article is to present a pragmatic review of the state of the art in the epidemiology, pathophysiology, diagnosis and treatment of anemia associated with chronic kidney disease. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-07-15 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/17284 oai:ojs.www.actamedicaportuguesa.com:article/17284 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/17284 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/17284 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/17284 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/17284/6697 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2022 Acta Médica Portuguesa http://creativecommons.org/licenses/by-nc/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2022 Acta Médica Portuguesa http://creativecommons.org/licenses/by-nc/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 35 No. 10 (2022): October; 758-764 Acta Médica Portuguesa; Vol. 35 N.º 10 (2022): Outubro; 758-764 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130656629850112 |